Intercure (INCR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.006x

Based on the latest financial reports, Intercure (INCR) has a cash flow conversion efficiency ratio of 0.006x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA2.32 Million ≈ $6.22K USD) by net assets (ILA396.36 Million ≈ $1.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Intercure to measure how much of total assets are equity-financed.

Intercure - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Intercure's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check INCR operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Intercure Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intercure ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LORDS CHLORO ALKALI ORD T (BSE) NSE:LORDSCHLO	N/A
Sinsin Pharmaceutical Co. Ltd KQ:002800	0.066x
Eonmetall Group Bhd KLSE:7217	0.060x
Major Cineplex Lifestyle Leasehold Property Fund BK:MJLF	0.015x
Webstep ASA OL:WSTEP	0.308x
JAS Asset PCL BK:J	0.016x
Fernheizwerk Neukölln Aktiengesellschaft F:FHW	N/A
Ananda Development Public Company Limited BK:ANAN	0.067x

Annual Cash Flow Conversion Efficiency for Intercure (2010–2025)

The table below shows the annual cash flow conversion efficiency of Intercure from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Intercure stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA396.36 Million ≈ $1.06 Million	ILA16.84 Million ≈ $45.15K	0.042x	+125.25%
2024-12-31	ILA397.67 Million ≈ $1.07 Million	ILA-66.93 Million ≈ $-179.43K	-0.168x	-43.43%
2023-12-31	ILA457.06 Million ≈ $1.23 Million	ILA-53.63 Million ≈ $-143.78K	-0.117x	-219.35%
2022-12-31	ILA521.48 Million ≈ $1.40 Million	ILA51.27 Million ≈ $137.45K	0.098x	+80.43%
2021-12-31	ILA459.19 Million ≈ $1.23 Million	ILA25.02 Million ≈ $67.08K	0.054x	+103.97%
2020-12-31	ILA292.11 Million ≈ $783.13K	ILA7.80 Million ≈ $20.92K	0.027x	+270.54%
2019-12-31	ILA256.20 Million ≈ $686.87K	ILA-4.01 Million ≈ $-10.76K	-0.016x	+79.27%
2018-12-31	ILA19.66 Million ≈ $52.71K	ILA-1.49 Million ≈ $-3.98K	-0.076x	-69.69%
2017-12-31	ILA20.68 Million ≈ $55.44K	ILA-921.03K ≈ $-2.47K	-0.045x	+8.33%
2016-12-31	ILA24.07 Million ≈ $64.53K	ILA-1.17 Million ≈ $-3.14K	-0.049x	+65.72%
2015-12-31	ILA11.95 Million ≈ $32.05K	ILA-1.69 Million ≈ $-4.54K	-0.142x	+94.79%
2014-12-31	ILA697.01K ≈ $1.87K	ILA-1.90 Million ≈ $-5.08K	-2.721x	-220.50%
2013-12-31	ILA3.92 Million ≈ $10.50K	ILA-3.33 Million ≈ $-8.92K	-0.849x	-433.44%
2012-12-31	ILA9.84 Million ≈ $26.37K	ILA-1.57 Million ≈ $-4.20K	-0.159x	-1056.85%
2011-12-31	ILA-51.72 Million ≈ $-138.66K	ILA-860.16K ≈ $-2.31K	0.017x	-93.72%
2010-12-31	ILA-12.03 Million ≈ $-32.26K	ILA-3.19 Million ≈ $-8.54K	0.265x	--

About Intercure

TA:INCR Israel Drug Manufacturers - Specialty & Generic

Market Cap

$44.19 Million

ILA16.48 Billion ILA

Market Cap Rank

#22367 Global

#306 in Israel

Share Price

ILA288.40

Change (1 day)

-0.24%

52-Week Range

ILA228.00 - ILA585.00

All Time High

ILA6317.95